ライフサイエンスコーパス: Haemophilus

1 intracytoplasmic membrane heme transport in Haemophilus.

2 the highest levels of Streptococcus (18.4%), Haemophilus (12.7%) and Neisseria (6.8%).

3 etry (MALDI-TOF MS) in the identification of Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella

4 espiratory pathogens belonging to the genera Haemophilus and Pseudomonas, colonized the early biofilm

5 pathogens, including Pseudomonas aeruginosa, Haemophilus, Aspergillus fumigatus, and nontuberculous m

6 creased abundance of Psuedomonas, Mycoplana, Haemophilus, Blautia, and Dorea genera in MS patients, w

7 Subsequently, 44 Haemophilus clinical isolates were collected, and 36 iso

8 to the role of P4 as an important factor for Haemophilus colonization and subsequent respiratory trac

9 ficantly higher relative abundances, whereas Haemophilus, Corynebacterium, Cellulosimicrobium and Cam

10 The Haemophilus cryptic genospecies (HCG) causes genital tra

11 Among infants with lower CCL5 levels, the Haemophilus-dominant microbiota profile was associated w

12 Haemophilus ducreyi (HD) and Treponema pallidum subspeci

13 s of CDTs from Escherichia coli (Ec-CDT) and Haemophilus ducreyi (Hd-CDT), which share limited amino

14 Haemophilus ducreyi 35000HP contains a homolog of the Cp

15 The Haemophilus ducreyi 35000HP genome encodes a homolog of

16 Haemophilus ducreyi causes chancroid, a genital ulcer di

17 Haemophilus ducreyi causes chancroid, a genital ulcer di

18 The finding that Haemophilus ducreyi causes lesions similar to yaws is pa

19 Haemophilus ducreyi causes the sexually transmitted dise

20 Haemophilus ducreyi causes the sexually transmitted dise

21 Haemophilus ducreyi encounters several classes of antimi

22 t (p)ppGpp was required for the virulence of Haemophilus ducreyi in humans.

23 y the role of macrophage polarization during Haemophilus ducreyi infection, we analyzed a panel of ma

24 Haemophilus ducreyi resists killing by antimicrobial pep

25 Here, we investigated whether Haemophilus ducreyi, a Gram-negative bacterium that caus

26 Haemophilus ducreyi, the causative agent of chancroid, h

27 Haemophilus ducreyi, the causative agent of chancroid, h

28 Haemophilus ducreyi, the etiologic agent of chancroid, e

29 Haemophilus ducreyi, the etiologic agent of chancroid, e

30 Haemophilus ducreyi, the etiologic agent of chancroid, h

31 In humans inoculated with Haemophilus ducreyi, there are host effects on the possi

32 cause skin infections in the Pacific islands-Haemophilus ducreyi-as causes of skin ulceration in a ya

33 ecies of bacteria: Neisseria gonorrhoeae and Haemophilus ducreyi.

34 r no changes in the prevalence of Neisseria, Haemophilus, Gemella, Leptotrichia, Solobacterium, Parvi

35 Haemophilus haemolyticus and nontypeable Haemophilus inf

36 Haemophilus haemolyticus has been recently discovered to

37 nontypeable (NT) Haemophilus influenzae from Haemophilus haemolyticus in respiratory-tract samples, b

38 We report seven cases of Haemophilus haemolyticus invasive disease detected in th

39 e also investigated their prevalences in 148 Haemophilus haemolyticus strains, a closely related spec

40 d three pathogenic, of the emerging pathogen Haemophilus haemolyticus.

41 Chlamydia and Haemophilus infections increase NLRP3, caspase-1, IL-1be

42 ekly challenged with a lysate of nontypeable Haemophilus influenza (NTHi), which induces COPD-type in

43 (1% rabies-vaccine recipients), one case of Haemophilus influenza meningitis (1% rabies-vaccine reci

44 s, Rubella, Mumps, trivalent MMR vaccine and Haemophilus influenza type B (HiB) vaccine.

45 rway inflammation in response to nontypeable Haemophilus influenza, which was associated with elevate

46 n is performed using the bacterial strain of Haemophilus influenza.

47 representing a reduced relative abundance of Haemophilus influenzae (35.3% [5.5-91.6] vs 6.7% [0.8-74

48 Haemophilus influenzae (Hi) causes respiratory tract inf

49 y to inhibit catalytic activity of DapE from Haemophilus influenzae (HiDapE) and ArgE from Escherichi

50 Haemophilus influenzae (MIC(50), </= 0.008 microg/mL; MI

51 pathogens were detected frequently, notably Haemophilus influenzae (mostly nontypeable) together wit

52 re Pseudomonas aeruginosa (n = 10 patients), Haemophilus influenzae (n = 12), Prevotella (n = 18), an

53 It is closely related to nontypeable Haemophilus influenzae (NT H. influenzae).

54 ta-lactamase-producing strain of nontypeable Haemophilus influenzae (NTHi 86-028NP) and an isogenic m

55 The mucosal pathogen nontypeable Haemophilus influenzae (NTHi) adheres to the respiratory

56 Hia is a major adhesin of nontypeable Haemophilus influenzae (NTHi) and has long been investig

57 Biofilms formed by nontypeable Haemophilus influenzae (NTHI) are central to the chronic

58 Haemophilus haemolyticus and nontypeable Haemophilus influenzae (NTHi) are closely related upper

59 by Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) are frequently implicated

60 Nontypeable Haemophilus influenzae (NTHI) are Gram-negative bacteria

61 istic human respiratory pathogen nontypeable Haemophilus influenzae (NTHI) are required for type IV p

62 ocator function is necessary for nontypeable Haemophilus influenzae (NTHI) behaviors that mediate dis

63 ram-negative commensal bacterium nontypeable Haemophilus influenzae (NTHI) can cause respiratory trac

64 Nontypeable Haemophilus influenzae (NTHi) exclusively infects humans

65 Nontypeable Haemophilus influenzae (NTHI) forms biofilms in the midd

66 Nontypeable Haemophilus influenzae (NTHi) frequently causes noninvas

67 Studies of nontypeable Haemophilus influenzae (NTHi) have demonstrated that a n

68 reptococcus pneumoniae (Spn) and nontypeable Haemophilus influenzae (NTHi) in stringently defined oti

69 xed Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) infections (M-OM) and thos

70 Nontypeable Haemophilus influenzae (NTHi) initiates infection by col

71 Nontypeable Haemophilus influenzae (NTHi) is a bacterium that reside

72 Nontypeable Haemophilus influenzae (NTHI) is a commensal inhabitant

73 Nontypeable Haemophilus influenzae (NTHi) is a commensal microorgani

74 Nontypeable Haemophilus influenzae (NTHI) is a common commensal and

75 Nontypeable Haemophilus influenzae (NTHI) is a Gram-negative bacteri

76 Nontypeable Haemophilus influenzae (NTHi) is a Gram-negative, opport

77 Nontypeable Haemophilus influenzae (NTHI) is a leading cause of oppo

78 Nontypeable Haemophilus influenzae (NTHI) is a leading cause of otit

79 Nontypeable Haemophilus influenzae (NTHi) is a major bacterial patho

80 Non-typeable Haemophilus influenzae (NTHi) is a major cause of mucosa

81 Nontypeable Haemophilus influenzae (NTHI) is a respiratory commensal

82 Nontypeable Haemophilus influenzae (NTHi) is an important bacterial

83 am-negative pathogenic bacterium nontypeable Haemophilus influenzae (NTHi) is surface exposed and a l

84 Nontypeable Haemophilus influenzae (NTHI) is the causative agent of

85 Nontypeable Haemophilus influenzae (NTHi) is the dominant bacterium

86 Nontypeable Haemophilus influenzae (NTHi) is the leading bacterial p

87 vaccine against nonencapsulated isolates of Haemophilus influenzae (NTHi) lies in the genetic divers

88 ere we examine the impact of the nontypeable Haemophilus influenzae (NTHI) ModA2 phasevarion on patho

89 Nontypeable Haemophilus influenzae (NTHi) persists in the airways in

90 Nontypeable Haemophilus influenzae (NTHi) was selected as a model pa

91 Nontypeable Haemophilus influenzae (NTHI), an opportunistic pathogen

92 Nontypeable Haemophilus influenzae (NTHI), an opportunistic pathogen

93 were calculated for pneumococcal, nontypable Haemophilus influenzae (NTHi), Moraxella catarrhalis, St

94 l collapse of biofilms formed by nontypeable Haemophilus influenzae (NTHI), those directed against a

95 ctions with pathogens, including nontypeable Haemophilus influenzae (NTHI), yet the reasons for this

96 asion by lung microbiota such as nontypeable Haemophilus influenzae (NTHi).

97 l impairment of phagocytosis for nontypeable Haemophilus influenzae (NTHI).

98 ce exposed to cigarette smoke or nontypeable Haemophilus influenzae (NTHi).

99 E) responses of ccl3(-/-)mice to nontypeable Haemophilus influenzae (NTHi).

100 by respiratory pathogens such as nontypeable Haemophilus influenzae (NTHi).

101 onization strategies employed by nontypeable Haemophilus influenzae (NTHi).

102 evelopment and colonization with nontypeable Haemophilus influenzae (NTHi).

103 diseases are commonly caused by nontypeable Haemophilus influenzae (NTHi).

104 tly colonized with bacteria [eg, nontypeable Haemophilus influenzae (NTHi)] that cause pulmonary infl

105 onfidence interval [CI], 1.90 and 10.19) and Haemophilus influenzae (OR, 2.04; 95% CI, 1.38 and 3.02)

106 (p = 0.001), NFkB activation by nontypeable Haemophilus influenzae (p = 0.001), TLR4 (p = 0.008) and

107 nces, most notably in potentially pathogenic Haemophilus influenzae (P = 2.7 x 10(-20)), from a preex

108 pathogens were Streptococcus pneumoniae and Haemophilus influenzae (type B and non-type B).

109 s simplex virus [n = 5], adenovirus [n = 5], Haemophilus influenzae [n = 5], and Streptococcus pneumo

110 Haemophilus influenzae also uses an enzyme, GlpQ, to hyd

111 colonization by Streptococcus pneumoniae and Haemophilus influenzae among children has been noted in

112 Neisseria meningitidis and ceftriaxone, and Haemophilus influenzae and ceftriaxone.

113 sensitivity and specificity for identifying Haemophilus influenzae and differentiating it from H. ha

114 activity has been achieved against wild-type Haemophilus influenzae and efflux-deficient mutants of E

115 ator to the respiratory pathogen nontypeable Haemophilus influenzae and identify the Haemophilus surf

116 s pneumoniae and the Gram-negative pathogens Haemophilus influenzae and Moraxella catarrhalis .

117 nization with Gram-negative bacteria such as Haemophilus influenzae and Moraxella catarrhalis was fou

118 animal models of the Gram-negative pathogens Haemophilus influenzae and Neisseria meningitidis We hyp

119 vaccination with conjugate vaccines against Haemophilus influenzae and Streptococcus pneumoniae has

120 Haemophilus influenzae and Streptococcus pneumoniae were

121 piratory syncytial virus; RSV) and bacteria (Haemophilus influenzae and Streptococcus pneumoniae) in

122 ion of EVI1 itself is induced by nontypeable Haemophilus influenzae and TNF-alpha in an NF-kappaB-dep

123 In the Gram-negative bacteria Haemophilus influenzae and Vibrio cholerae, the master r

124 Immunoglobulin (Ig)A proteases of Haemophilus influenzae are highly specific endopeptidase

125 ococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae are the major causes of conjuncti

126 Here, using non-typeable Haemophilus influenzae as a model organism, we report th

127 5922 (0.008 to 0.03 mug/ml and 30 to 36 mm), Haemophilus influenzae ATCC 49247 (0.002 to 0.015 mug/ml

128 pneumoniae ATCC 49619 (disk and broth), and Haemophilus influenzae ATCC 49247 (disk and broth).

129 ureus ATCC 29213 (MIC range, 1 to 4 mug/ml), Haemophilus influenzae ATCC 49247 (MIC and disk diffusio

130 and ATCC 25923, Escherichia coli ATCC 25922, Haemophilus influenzae ATCC 49247, and Streptococcus pne

131 23, Streptococcus pneumoniae ATCC 49619, and Haemophilus influenzae ATCC 4927 strains were evaluated.

132 in Southern England immunized with DTaP5/IPV/Haemophilus influenzae b (Hib-TT) vaccine at 2-3-4 month

133 syncytial virus, parainfluenza viruses, and Haemophilus influenzae being the most common.

134 We present the Arg160His mutation of Haemophilus influenzae carbonic anhydrase (HICA), which

135 ve a significantly lower risk of nontypeable Haemophilus influenzae carriage in particular (relative

136 Pneumococcus, meningococcus, and Haemophilus influenzae cause a similar spectrum of infec

137 ella kingae (HACEK) clinical isolates and 20 Haemophilus influenzae clinical isolates.

138 Non-typeable Haemophilus influenzae contains an N(6)-adenine DNA-meth

139 Using Haemophilus influenzae Eagan strains expressing well-cha

140 son of derivatives of a laboratory strain of Haemophilus influenzae expressing either surface-associa

141 Unencapsulated Haemophilus influenzae frequently causes noninvasive upp

142 marker for differentiating nontypeable (NT) Haemophilus influenzae from Haemophilus haemolyticus in

143 terial burden and a significant outgrowth of Haemophilus influenzae from the existing microbiota of s

144 The Haemophilus influenzae HMW1 adhesin is an N-linked glyco

145 ficiency further affected internalization of Haemophilus influenzae in bronchial epithelial cells.

146 d for TolR is of the periplasmic domain from Haemophilus influenzae in which N- and C-terminal residu

147 In this study, we found that nontypeable Haemophilus influenzae induces the association of Itch w

148 he survival rate after a lethal non-typeable Haemophilus influenzae infection in wild-type mice, but

149 tudy persistent Streptococcus pneumoniae and Haemophilus influenzae infections, to show that structur

150 Haemophilus influenzae is a Gram-negative human pathogen

151 Nontypeable Haemophilus influenzae is a major cause of localized res

152 Haemophilus influenzae is a rare cause of soft tissue in

153 Haemophilus influenzae is a significant causative agent

154 Non-typeable Haemophilus influenzae is an opportunistic pathogen of t

155 lmonary inflammation induced by non-typeable Haemophilus influenzae is significantly attenuated in IR

156 configurations were predicted in nontypeable Haemophilus influenzae isolates based on the presence of

157 e operon was significantly more prevalent in Haemophilus influenzae isolates causing otitis media and

158 -resolution X-ray structure determination of Haemophilus influenzae KDO8PP bound to KDO/VO3(-) and Ba

159 d antimicrobial activity against a strain of Haemophilus influenzae lacking its major efflux pump.

160 we have shown that the C-terminal domain of Haemophilus influenzae LpoA (HiLpoA) has a highly conser

161 , and detailed enzymatic characterization of Haemophilus influenzae LpxH (HiLpxH).

162 ed as having meningococcal, pneumococcal, or Haemophilus influenzae meningitis in the period 1977-200

163 or upon acute exposure to either nontypeable Haemophilus influenzae or ovalbumin.

164 ts of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine (PHiD

165 Haemophilus influenzae protein F (PF) is an important vi

166 m phylogenetically distant Aquifex aeolicus, Haemophilus influenzae Rd, and Synechocystis sp. were fo

167 lls) to the respiratory pathogen nontypeable Haemophilus influenzae resulted in a marked increase in

168 us, while challenge of Trim29(-/-) mice with Haemophilus influenzae resulted in lethal lung inflammat

169 The introduction of the Haemophilus influenzae serotype b (Hib) conjugate vaccin

170 tis in a healthy adult patient, secondary to Haemophilus influenzae serotype f infection, and we revi

171 Haemophilus influenzae strains are classified as typeabl

172 e show that glucocorticoids and non-typeable Haemophilus influenzae synergistically upregulate IRAK-M

173 abs positive for Streptococcus pneumoniae or Haemophilus influenzae than were males (OR 9.09; 95% CI

174 Signaling mechanisms used by Haemophilus influenzae to adapt to conditions it encount

175 Upon exposure of serum-sensitive Haemophilus influenzae to human serum, Ecb protected the

176 of a collection of compound fragments using Haemophilus influenzae TrmD identified inhibitory, fused

177 n the first detection of 2 cases of invasive Haemophilus influenzae type a (Hia) disease in Italy.

178 t diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (DTaP-IPV-Hib) administere

179 s-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (DTaP-IPV-Hib) vaccine sin

180 A conjugate vaccine containing Haemophilus influenzae type b (Hib) and group C meningoc

181 treptococcus pneumoniae (S. pneumoniae), and Haemophilus influenzae type b (Hib) are three most commo

182 ed (DTaP), inactivated poliovirus (IPV), and Haemophilus influenzae type b (Hib) conjugate vaccine (D

183 e United States in the early 1990s, when the Haemophilus influenzae type b (Hib) conjugate vaccine fo

184 Haemophilus influenzae type b (Hib) conjugate vaccine, d

185 The widespread use of Haemophilus influenzae type b (Hib) conjugate vaccines h

186 The incidence of invasive Haemophilus influenzae type b (Hib) disease has signific

187 ng hospital in Malawi during introduction of Haemophilus influenzae type b (Hib) vaccination and the

188 rst country in Africa to introduce conjugate Haemophilus influenzae type b (Hib) vaccine, which, as i

189 Streptococcus pneumoniae polysaccharide and Haemophilus influenzae type b (Hib) vaccines in ITP pati

190 Protection against Haemophilus influenzae type b (Hib), a rapidly invading

191 ribitol (PRP) polysaccharides extracted from Haemophilus influenzae type b (Hib), and the correspondi

192 duction of vaccines against pneumococcus and Haemophilus influenzae type b (the most important causes

193 become the predominant invasive pathogen as Haemophilus influenzae type b and pneumococcal vaccine u

194 ca, the widespread use of vaccines targeting Haemophilus influenzae type b and Streptococcus pneumoni

195 and of occult bacteremia since the advent of Haemophilus influenzae type b and Streptococcus pneumoni

196 -tetanus-acellular pertussis-inactived polio-Haemophilus influenzae type b combined vaccine (DTaP-IPV

197 C, W, Y polysaccharide vaccine (PsACWY); or Haemophilus influenzae type b conjugate vaccine (Hib-TT)

198 Literature on hepatitis B, rotavirus, Haemophilus influenzae type b conjugate, and pneumococca

199 clinical significance and characteristics of Haemophilus influenzae type b genogroup strains isolated

200 a, tetanus, pertussis, measles, rubella, and Haemophilus influenzae type b vaccine antigens were comp

201 s-acellular pertussis-inactivated poliovirus/Haemophilus influenzae type b vaccine; age 6/10/ 14 week

202 r pertussis, inactivated polio, hepatitis B, Haemophilus influenzae type b vaccines); (2) 4CMenB at 2

203 ng countries in 2015, using pneumococcal and Haemophilus influenzae type b vaccines.

204 , and whole-cell pertussis; hepatitis B; and Haemophilus influenzae type b) and pneumococcal vaccine.

205 , tetanus, pertussis, hepatitis B virus, and Haemophilus influenzae type b), yellow fever, measles, a

206 ent vaccine (diphtheria, tetanus, pertussis, Haemophilus influenzae type b, and hepatitis B) at 6, 10

207 include pneumococcus, group B Streptococcus, Haemophilus influenzae type b, and meningococcus vaccine

208 to characterise disease syndromes caused by Haemophilus influenzae type b, pneumococcus, rotavirus,

209 cine priming, before a booster of a combined Haemophilus influenzae type b-MenC conjugate vaccine and

210 The bacterium Haemophilus influenzae typically colonizes the human upp

211 the sialic acid-specific SBP, SiaP, from the Haemophilus influenzae virulence-related SiaPQM TRAP tra

212 ctivity against an efflux-negative strain of Haemophilus influenzae was 4- to 8-fold higher, the comb

213 Haemophilus influenzae was present in more adenoids from

214 caused by either Streptococcus pneumoniae or Haemophilus influenzae were compared for pathogen-specif

215 phtericum and Corynebacterium propinquum and Haemophilus influenzae were significantly more abundant

216 enes, Staphylococcus aureus, and potentially Haemophilus influenzae).

217 Pathogenic bacteria such as Haemophilus influenzae, a major cause of lower respirato

218 ibrocytes) are able to recognize nontypeable Haemophilus influenzae, a major pathogen of middle ear i

219 ccus aureus, 10 Streptococcus pneumoniae, 10 Haemophilus influenzae, and 5 Escherichia coli isolates

220 orins from Neisseriae, Shigella, Salmonella, Haemophilus influenzae, and Fusobacterium nucleatum, whi

221 Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis are th

222 antitative PCR for Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were p

223 ovirus, bocavirus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were s

224 c airway bacteria (Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis) were

225 as Escherichia coli, Neisseria meningitidis, Haemophilus influenzae, and Pasteurella multocida.

226 phocholine, phosphocholine-modified LPS from Haemophilus influenzae, and phosphocholine-modified prot

227 phylococci (CoNS), Streptococcus pneumoniae, Haemophilus influenzae, and Pseudomonas aeruginosa.

228 eumoniae, Staphylococcus aureus, Nontypeable Haemophilus influenzae, and Pseudomonas aeruginosa.

229 thogens: Pseudomonas aeruginosa, nontypeable Haemophilus influenzae, and Salmonella enterica serovar

230 ptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae, and Staphylococcus aureus.

231 Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae are

232 atory tract pathogens Moraxella catarrhalis, Haemophilus influenzae, and Streptococcus pneumoniae, bu

233 is caused mainly by Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae, in

234 eudomonas aeruginosa, Staphylococcus aureus, Haemophilus influenzae, Aspergillus species, Streptococc

235 protection against PC-expressing nontypeable Haemophilus influenzae, but not PC-negative nontypeable

236 , we turned our attention to bacteria, i.e., Haemophilus influenzae, expressing cell-surface adhesins

237 Novel mouse models of Chlamydia, Haemophilus influenzae, influenza, and respiratory syncy

238 a catarrhalis, Streptococcus pneumoniae, and Haemophilus influenzae, is associated with later develop

239 tly from CSF specimens: Escherichia coli K1, Haemophilus influenzae, Listeria monocytogenes, Neisseri

240 ccines with/without protein D of nontypeable Haemophilus influenzae, M. catarrhalis has become a high

241 were cultured for Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staph

242 piratory pathogens Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staph

243 irways with the pathogenic bacterial strains Haemophilus influenzae, Moraxella catarrhalis, and Strep

244 y associated with bacterial coinfection with Haemophilus influenzae, Moraxella catarrhalis, or Strept

245 We assessed this association for Haemophilus influenzae, Moraxella catarrhalis, Staphyloc

246 lude Escherichia coli, Campylobacter jejuni, Haemophilus influenzae, Neisseria meningitidis, and Past

247 Infection with Haemophilus influenzae, Neisseria meningitidis, and Stre

248 cterial pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, Mycoplas

249 used to vaccinate children globally against Haemophilus influenzae, pneumococcus, and meningococcus.

250 The arfA hairpins from Haemophilus influenzae, Proteus mirabilis, Vibrio fische

251 influenzae, but not PC-negative nontypeable Haemophilus influenzae, relative to wild-type mice.

252 morphism in humans evades TbpA variants from Haemophilus influenzae, revealing a functional basis for

253 tococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae, S suis) and O tsutsugamushi, Ric

254 and 24 months of age were cultured to detect Haemophilus influenzae, Streptococcus pneumoniae, Moraxe

255 usters characterized by enrichment of either Haemophilus influenzae, Streptococcus, Corynebacterium,

256 Working with the bacterium Haemophilus influenzae, we found that MolBC-A functions

257 the sialic acid TRAP transporter SiaPQM from Haemophilus influenzae, where the membrane proteins are

258 een H. parainfluenzae and its close relative Haemophilus influenzae, which is also commonly carried w

259 w that EVI1 negatively regulates nontypeable Haemophilus influenzae- and TNF-alpha-induced NF-kappaB-

260 nd in some regions, for all pathogens except Haemophilus influenzae.

261 ssue, which included known pathogens such as Haemophilus influenzae.

262 hylococcus and Gram-negative bacteria and to Haemophilus influenzae.

263 t line of defense against the human pathogen Haemophilus influenzae.

264 ococcus pneumoniae, and 54% for non-typeable Haemophilus influenzae.

265 were previously misidentified as nontypeable Haemophilus influenzae.

266 ainst efflux-negative strains of E. coli and Haemophilus influenzae.

267 s successful in creating unmarked mutants in Haemophilus influenzae.

268 crobial peptides (sap operon) in nontypeable Haemophilus influenzae.

269 ccus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae.

270 ng Streptococcus pneumoniae and non-typeable Haemophilus influenzae.

271 Here we identified Haemophilus lipoprotein e (P4) as a receptor for ECM pro

272 The genera Haemophilus (log2 fold change -2.15, P=.003), Dialister

273 t incursions of Streptococcus, Moraxella, or Haemophilus marked virus-associated ARIs.

274 pecific bacteria such as Enterobacteriaceae, Haemophilus, Methylobacterium, and Ralstonia species wer

275 cts were uniquely enriched in members of the Haemophilus, Neisseria, Fusobacterium, and Porphyromonas

276 ond their ability to mediate DNA transfer in Haemophilus, OMV stimulation of host immunomodulatory cy

277 le profiles were marked by high abundance of Haemophilus or Streptococcus.

278 Haemophilus parainfluenzae is a nutritionally fastidious

279 Streptococcus mitis, Rothia mucilaginosa and Haemophilus parainfluenzae were the most significantly a

280 ubation of asthmatic airway macrophages with Haemophilus parainfluenzae, a uniquely expanded potentia

281 his technology for the identification of 103 Haemophilus parainfluenzae, Aggregatibacter aphrophilus,

282 lobacter gracilis, Capnocytophaga granulosa, Haemophilus parainfluenzae, and Lautropia mirabilis were

283 ardiobacterium hominis, Gemella haemolysans, Haemophilus parainfluenzae, Kingella oralis, Lautropia m

284 05); 1 prominent component of this group was Haemophilus parainfluenzae.

285 Haemophilus parasuis causes Glasser's disease and pneumo

286 Haemophilus parasuis is a diverse bacterial species that

287 Haemophilus parasuis is an opportunistic pathogen that c

288 Haemophilus parasuis is the causative agent of Glasser's

289 y 56% identical amino acids, both FH-binding Haemophilus proteins similarly interacted with the compl

290 distinguish H. haemolyticus from its closest Haemophilus relatives and provide clues to the identity

291 We developed mouse models of Chlamydia and Haemophilus respiratory infection-mediated, ovalbumin-in

292 obiota diversity (P = .009) and dominance of Haemophilus species operational taxonomic units (P = .01

293 alidated using a panel of well-characterized Haemophilus spp.

294 The occurrence and significance of Haemophilus spp. isolated from the genitourinary tract a

295 In particular, Haemophilus spp. were depleted in individuals with RA at

296 activity among staphylococci, streptococci, Haemophilus spp., and Moraxella catarrhalis were minimal

297 We identified Haemophilus, Streptococcus, Neisseria, and Veillonella s

298 able Haemophilus influenzae and identify the Haemophilus surface protein E (PE) as a new plasminogen-

299 und heme, whose acquisition is essential for Haemophilus survival.

300 First characterized as transformasomes in Haemophilus, these membranous blebs facilitate transfer